Teva: Warren Buffett Messed Things Up For Short-Sellers - Bloomberg
Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations - YouTube
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
Teva Gets Generic Price-Fixing Securities Suits Consolidated
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Glaxo's Win in Case Against Teva Lifts Other Drugmakers - Bloomberg
Teva CEO Has Doubts About Making Generic-Drug Ingredients in the U.S. | Barron's
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Soriot not moving to Teva - Bloomberg - Globes
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva, Allergan ready to pay $5B to settle thousands of opioid lawsuits (TEVA) | Seeking Alpha
Teva Generic Price-Fixing Securities Suit Gets Class Status (1)
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
Drug giants line up for Irish legal battle over patents - Independent.ie
Teva Is On The Prowl And Its Investors Are Taking Notice | Mint
Teva stock drops after conspiracy allegations on hiking drug prices
Allergan becomes largest shareholder in Teva - Globes
Teva Pharmaceuticals (TEVA) Stock Gets Upgraded at HSBC - TheStreet
Teva (TEVA), AbbVie (ABBV) to Pay $161.5 Million in West Virginia Opioid Case - Bloomberg
Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict - Bloomberg
Israel's Teva offering free drugs to settle U.S. opiods case - Business - Haaretz.com
Cash-strapped Teva closes in on women's health sale No. 2: report | Fierce Pharma
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
How Uggs, Hoka, and Tevas Helped Build Deckers' $2.5 Billion Ugly-Shoe Empire - Bloomberg
